Healthcare provider profile · identity verified

Paul Elsen, MD

Family Practice · GRAND RAPIDS, MI · NPI 1073567178

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	908	265
Lisinopril	Lisinopril	530	146
Amlodipine Besylate	Amlodipine Besylate	490	134
Levothyroxine Sodium	Levothyroxine Sodium	442	112
Omeprazole	Omeprazole	364	114
Metoprolol Succinate	Metoprolol Succinate	354	99
Losartan Potassium	Losartan Potassium	321	94
Tamsulosin Hcl	Tamsulosin Hcl	278	86
Rosuvastatin Calcium	Rosuvastatin Calcium	277	86
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	231	45
Hydrochlorothiazide	Hydrochlorothiazide	209	67
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	199	58
Eliquis	Apixaban	185	35
Metformin Hcl Er	Metformin Hcl	185	56
Metformin Hcl	Metformin Hcl	178	55
Simvastatin	Simvastatin	172	49
Trazodone Hcl	Trazodone Hcl	166	46
Alprazolam	Alprazolam	164	37
Gabapentin	Gabapentin	162	52
Furosemide	Furosemide	132	44
Pantoprazole Sodium	Pantoprazole Sodium	129	44
Citalopram Hbr	Citalopram Hydrobromide	128	37
Sertraline Hcl	Sertraline Hcl	126	37
Zolpidem Tartrate	Zolpidem Tartrate	120	21
Fluticasone Propionate	Fluticasone Propionate	106	41
Lorazepam	Lorazepam	106	24
Albuterol Sulfate Hfa	Albuterol Sulfate	104	43
Jardiance	Empagliflozin	97	23
Tramadol Hcl	Tramadol Hcl	97	20
Pravastatin Sodium	Pravastatin Sodium	96	28
Allopurinol	Allopurinol	94	25
Carvedilol	Carvedilol	91	28
Meloxicam	Meloxicam	87	33
Escitalopram Oxalate	Escitalopram Oxalate	83	22
Finasteride	Finasteride	83	23
Duloxetine Hcl	Duloxetine Hcl	82	20
Glimepiride	Glimepiride	79	23
Atenolol	Atenolol	77	20
Pioglitazone Hcl	Pioglitazone Hcl	77	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	23
Montelukast Sodium	Montelukast Sodium	69	22
Bupropion Xl	Bupropion Hcl	66	21
Donepezil Hcl	Donepezil Hcl	62	14
Metoprolol Tartrate	Metoprolol Tartrate	62	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	61	15
Prednisone	Prednisone	56	31
Fluoxetine Hcl	Fluoxetine Hcl	54	13
Alendronate Sodium	Alendronate Sodium	50	19
Lovastatin	Lovastatin	50	14
Potassium Chloride	Potassium Chloride	49	14
Clopidogrel	Clopidogrel Bisulfate	48	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	18
Famotidine	Famotidine	48	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	16
Olmesartan Medoxomil	Olmesartan Medoxomil	46	18
Doxazosin Mesylate	Doxazosin Mesylate	43	12
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	42	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	11
Solifenacin Succinate	Solifenacin Succinate	37	13
Celecoxib	Celecoxib	36	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Lansoprazole	Lansoprazole	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Ibuprofen	Ibuprofen	33	14
Propranolol Hcl	Propranolol Hcl	33	12
Xarelto	Rivaroxaban	33	11
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Trospium Chloride	Trospium Chloride	30	12
Amitriptyline Hcl	Amitriptyline Hcl	29	11
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Estradiol	Estradiol	29	13
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Amoxicillin	Amoxicillin	27	23
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Cephalexin	Cephalexin	26	22
Eszopiclone	Eszopiclone	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Ozempic	Semaglutide	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	20
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Naproxen	Naproxen	22	15
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Temazepam	Temazepam	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Glipizide	Glipizide	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Ramipril	Ramipril	15	suppressed
Risperidone	Risperidone	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ramelteon	Ramelteon	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Azithromycin	Azithromycin	12	11
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error